Jin YN, Zhang W. Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients. World J Gastroenterol 2024; 30(16): 2285-2286 [PMID: 38690019 DOI: 10.3748/wjg.v30.i16.2285]
Corresponding Author of This Article
Wei Zhang, MD, PhD, Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, No. 321 Zhongshan Road, Nanjing 210000, Jiangsu Province, China. kimmysai@126.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Apr 28, 2024; 30(16): 2285-2286 Published online Apr 28, 2024. doi: 10.3748/wjg.v30.i16.2285
Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients
Ya-Ni Jin, Wei Zhang
Ya-Ni Jin, Wei Zhang, Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, Jiangsu Province, China
Author contributions: Jin YN wrote the letter; Zhang W revised the letter.
Conflict-of-interest statement: All the authors declare that they have no competing interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wei Zhang, MD, PhD, Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, No. 321 Zhongshan Road, Nanjing 210000, Jiangsu Province, China. kimmysai@126.com
Received: January 16, 2024 Peer-review started: January 16, 2024 First decision: February 26, 2024 Revised: March 7, 2024 Accepted: April 2, 2024 Article in press: April 2, 2024 Published online: April 28, 2024 Processing time: 101 Days and 2 Hours
Abstract
This is a retrospective study focused on recompensation after transjugular intrahepatic portosystemic shunt (TIPS) procedure. The authors confirmed TIPS could be a treatment for recompensation of patients with cirrhosis according to Baveno VII. The paper identified age and post-TIPS portal pressure gradient as independent predictors of recompensation in patients with decompensated cirrhosis after TIPS. These results need to be validated in a larger prospective cohort.
Core Tip: Approximately one-third of the patients experienced cirrhosis recompensation following transjugular intrahepatic portosystemic shunt (TIPS) and post-TIPS portal pressure gradient reduction below 12 mmHg contributes to the occurrence of recompensation. The selection of a smaller diameter (6 mm) stent may be an effective measure to reduce portal vein pressure while decreasing the incidence of postoperative hepatic encephalopathy.
